Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FEPHE
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,822
Award facts
- Contract value 100% obligated
- $13,822.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was awarded a delivery order valued at $13,822.24 by the Defense Logistics Agency on January 6, 2026. The delivery order, issued under firm fixed-price terms with no set-aside designation, calls for the supply of pharmaceutical products and medical consumables to support Department of Defense healthcare operations. This award falls under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) designated SPE2DR, which was established under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative on November 13, 2025, with a ceiling value of $499,999,999 extending through December 31, 2036.
The PPV-G GEN V represents a $30.3 billion government-wide acquisition strategy designed to streamline pharmaceutical supply chain management for the military health system globally. As a PPV-G GEN V regional prime vendor contractor, DMS Pharmaceutical Group is authorized to supply a comprehensive portfolio including branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, and specialty pharmaceuticals such as oncology treatments, immunosuppressants, and emergency medications. The company's delivery order activity through the Defense Logistics Agency's Medical Supply Chain division, with awards ranging from under $100 to over $115,000, demonstrates its established capability to fulfill the diverse pharmaceutical requirements of federal military medical facilities worldwide.
Quick answers
Who was awarded contract SPE2DU26FEPHE?
SPE2DU26FEPHE was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DU26FEPHE worth?
The government has obligated $13,822 on SPE2DU26FEPHE.
Is contract SPE2DU26FEPHE an order under another contract?
Yes. SPE2DU26FEPHE is a delivery order under SPE2DU25D9418, an indefinite delivery contract.
Was contract SPE2DU26FEPHE competed?
The extent of competition for SPE2DU26FEPHE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award